[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fj2EjljwnQa-3hv264a0FhcvhdfKFG03alRU-vpU5_h8":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":32,"phaseBuckets":83,"rows":90},"Endeavor Health",[4],109,false,24,5,726050,21,62,[14,17,20,22,24,26,28,30],{"name":15,"count":16},"Prostate Cancer",4,{"name":18,"count":19},"Postoperative Pain",3,{"name":21,"count":19},"Dysmenorrhea",{"name":23,"count":19},"Pelvic Pain",{"name":25,"count":19},"Breast Cancer",{"name":27,"count":19},"Asthma",{"name":29,"count":19},"Stress Urinary Incontinence",{"name":31,"count":19},"Pain",[33,38,43,48,53,58,63,68,73,78],{"nctId":34,"briefTitle":35,"date":36,"intervention":37},"NCT03893734","Effect of Methadone and Hydromorphone on the QT Interval After Anesthesia and Surgery","2020-08-12","methadone",{"nctId":39,"briefTitle":40,"date":41,"intervention":42},"NCT03168958","Methadone and Quality of Postoperative Recovery","2021-05-25","Methadone",{"nctId":44,"briefTitle":45,"date":46,"intervention":47},"NCT05626621","Efficacy of Azelastine and Mometasone Irrigation in Comparison to Nasal Sprays in Patients With Chronic Rhinitis","2025-08","Azelastine (137 mcg\u002Fspray) Nasal Spray and Mometasone (50 mcg\u002Fspray) Nasal Spray",{"nctId":49,"briefTitle":50,"date":51,"intervention":52},"NCT03491761","Intra-articular Platelet-Rich Plasma Compared With Viscosupplementation in the Treatment of Knee Osteoarthritis","2025-12","PRP Treatment",{"nctId":54,"briefTitle":55,"date":56,"intervention":57},"NCT06074380","Non Inferiority Trial Investigating Surfactants Administered Via MIST","2025-12-30","MIST surfactant",{"nctId":59,"briefTitle":60,"date":61,"intervention":62},"NCT06007547","Prophylactic Minimally Invasive Surfactant Evaluation","2025-12-31","Poractant Alfa",{"nctId":64,"briefTitle":65,"date":66,"intervention":67},"NCT06004674","Using Placental Pathology to Prevent Recurrent Adverse Pregnancy Outcomes: A Pilot Project","2026-03","Lovenox 40mg",{"nctId":69,"briefTitle":70,"date":71,"intervention":72},"NCT05795413","Quality of Recovery From Mastectomy With and Without PECS Blocks","2026-04","Liposomal bupivacaine",{"nctId":74,"briefTitle":75,"date":76,"intervention":77},"NCT07405554","Zinc Supplementation With Botulinum Toxin for Overactive Bladder","2026-05","Zinc Citrate Oral",{"nctId":79,"briefTitle":80,"date":81,"intervention":82},"NCT02670161","Quality Improvement and Practice Based Research in Neurology Using the EMR","2026-12","Listed for each disorder below, up to three drugs per disorder",[84,85,86,87,88,89],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[91,184,211,238,256,280,298,316,339,357,378,410,431,460,480,506,527,545,570,598,616,640,665,693,711,741,766,794,812,838,856,883,901,919,937,962,984,1002,1032,1050,1076,1103,1129,1152,1176,1204,1222,1240,1258,1281,1305,1331,1349,1374,1409,1434,1456,1474,1499,1523,1550],{"intervention":42,"totalTrials":92,"cells":93},7,{"EARLY_PHASE1":94,"PHASE1":97,"PHASE2":99,"PHASE3":101,"PHASE4":103,"NA":182},{"trials":95,"activeCount":96},[],0,{"trials":98,"activeCount":96},[],{"trials":100,"activeCount":96},[],{"trials":102,"activeCount":96},[],{"trials":104,"activeCount":181,"soonestReadout":36},[105,115,125,135,146,159,172],{"nctId":106,"briefTitle":107,"status":108,"phases":109,"primaryCompletion":110,"completion":110,"start":111,"enrollment":112,"conditions":113,"interventions":114},"NCT04525898","Intraoperative Methadone for Postoperative Pain Control After Thoracic Surgery","TERMINATED",[88],"2021-02-01","2019-10-09",40,[18],[42],{"nctId":34,"briefTitle":35,"status":116,"phases":117,"primaryCompletion":36,"completion":118,"start":119,"enrollment":120,"conditions":121,"interventions":123},"RECRUITING",[88],"2020-12-23","2018-05-01",140,[122],"EKG-QT Prolongation",[37,124],"Hydromorphone",{"nctId":126,"briefTitle":127,"status":128,"phases":129,"primaryCompletion":130,"completion":130,"start":131,"enrollment":132,"conditions":133,"interventions":134},"NCT01546948","Intraoperative Opioids and Postoperative Recovery After Hepatobiliary or Foregut Surgery","COMPLETED",[88],"2018-06","2011-08",60,[18],[42,124],{"nctId":136,"briefTitle":137,"status":138,"phases":139,"primaryCompletion":140,"completion":141,"start":142,"enrollment":143,"conditions":144,"interventions":145},"NCT03084588","Methadone and Interscalene Block for Shoulder Surgery","UNKNOWN",[88],"2019-07","2021-07","2016-07",100,[31],[37],{"nctId":147,"briefTitle":148,"status":128,"phases":149,"primaryCompletion":150,"completion":151,"start":152,"enrollment":153,"conditions":154,"interventions":157},"NCT01542645","The Effect of Choice of Intraoperative Opioid on Postoperative Pain",[88],"2013-11","2014-09","2010-09",164,[155,156],"Pain, Postoperative","Chronic Pain",[42,158],"Fentanyl",{"nctId":160,"briefTitle":161,"status":128,"phases":162,"primaryCompletion":142,"completion":163,"start":164,"enrollment":165,"conditions":166,"interventions":171},"NCT02107339","Methadone and Hydromorphone For Spinal Surgery",[88],"2017-09","2014-03",120,[167,168,169,170],"Hydromorphone Use","Acute Postoperative Pain","Patient Satisfaction","Chronic Persistent Surgical Pain",[42,124],{"nctId":39,"briefTitle":40,"status":116,"phases":173,"primaryCompletion":41,"completion":174,"start":175,"enrollment":176,"conditions":177,"interventions":179},[88],"2021-07-25","2018-12-25",130,[178],"Quality of Recovery Scores",[42,180],"Saline",2,{"trials":183,"activeCount":96},[],{"intervention":124,"totalTrials":19,"cells":185},{"EARLY_PHASE1":186,"PHASE1":188,"PHASE2":190,"PHASE3":192,"PHASE4":194,"NA":209},{"trials":187,"activeCount":96},[],{"trials":189,"activeCount":96},[],{"trials":191,"activeCount":96},[],{"trials":193,"activeCount":96},[],{"trials":195,"activeCount":208,"soonestReadout":36},[196,200,204],{"nctId":34,"briefTitle":35,"status":116,"phases":197,"primaryCompletion":36,"completion":118,"start":119,"enrollment":120,"conditions":198,"interventions":199},[88],[122],[37,124],{"nctId":126,"briefTitle":127,"status":128,"phases":201,"primaryCompletion":130,"completion":130,"start":131,"enrollment":132,"conditions":202,"interventions":203},[88],[18],[42,124],{"nctId":160,"briefTitle":161,"status":128,"phases":205,"primaryCompletion":142,"completion":163,"start":164,"enrollment":165,"conditions":206,"interventions":207},[88],[167,168,169,170],[42,124],1,{"trials":210,"activeCount":96},[],{"intervention":212,"totalTrials":208,"cells":213},"Naproxen Sodium 550mg",{"EARLY_PHASE1":214,"PHASE1":216,"PHASE2":218,"PHASE3":220,"PHASE4":222,"NA":236},{"trials":215,"activeCount":96},[],{"trials":217,"activeCount":96},[],{"trials":219,"activeCount":96},[],{"trials":221,"activeCount":96},[],{"trials":223,"activeCount":208,"soonestReadout":228},[224],{"nctId":225,"briefTitle":226,"status":116,"phases":227,"primaryCompletion":228,"completion":229,"start":230,"enrollment":231,"conditions":232,"interventions":234},"NCT06861920","NSAID Use for Treating Dysmenorrhea and Preventing Chronic Pelvic Pain (NSAID HEAL)",[88],"2030-04","2030-07","2025-04-07",600,[21,233,23],"Chronic Pelvic Pain",[212,235],"Extended Release Acetaminophen",{"trials":237,"activeCount":96},[],{"intervention":235,"totalTrials":208,"cells":239},{"EARLY_PHASE1":240,"PHASE1":242,"PHASE2":244,"PHASE3":246,"PHASE4":248,"NA":254},{"trials":241,"activeCount":96},[],{"trials":243,"activeCount":96},[],{"trials":245,"activeCount":96},[],{"trials":247,"activeCount":96},[],{"trials":249,"activeCount":208,"soonestReadout":228},[250],{"nctId":225,"briefTitle":226,"status":116,"phases":251,"primaryCompletion":228,"completion":229,"start":230,"enrollment":231,"conditions":252,"interventions":253},[88],[21,233,23],[212,235],{"trials":255,"activeCount":96},[],{"intervention":47,"totalTrials":208,"cells":257},{"EARLY_PHASE1":258,"PHASE1":260,"PHASE2":262,"PHASE3":264,"PHASE4":266,"NA":278},{"trials":259,"activeCount":96},[],{"trials":261,"activeCount":96},[],{"trials":263,"activeCount":96},[],{"trials":265,"activeCount":96},[],{"trials":267,"activeCount":208,"soonestReadout":46},[268],{"nctId":44,"briefTitle":45,"status":116,"phases":269,"primaryCompletion":46,"completion":270,"start":271,"enrollment":272,"conditions":273,"interventions":275},[88],"2026-08","2022-11-23",81,[274],"Chronic Rhinitis",[47,276,277],"Mometasone Nasal Irrigation","Mometasone (1 mg) and Azelastine (1 mg) Nasal Irrigation",{"trials":279,"activeCount":96},[],{"intervention":276,"totalTrials":208,"cells":281},{"EARLY_PHASE1":282,"PHASE1":284,"PHASE2":286,"PHASE3":288,"PHASE4":290,"NA":296},{"trials":283,"activeCount":96},[],{"trials":285,"activeCount":96},[],{"trials":287,"activeCount":96},[],{"trials":289,"activeCount":96},[],{"trials":291,"activeCount":208,"soonestReadout":46},[292],{"nctId":44,"briefTitle":45,"status":116,"phases":293,"primaryCompletion":46,"completion":270,"start":271,"enrollment":272,"conditions":294,"interventions":295},[88],[274],[47,276,277],{"trials":297,"activeCount":96},[],{"intervention":277,"totalTrials":208,"cells":299},{"EARLY_PHASE1":300,"PHASE1":302,"PHASE2":304,"PHASE3":306,"PHASE4":308,"NA":314},{"trials":301,"activeCount":96},[],{"trials":303,"activeCount":96},[],{"trials":305,"activeCount":96},[],{"trials":307,"activeCount":96},[],{"trials":309,"activeCount":208,"soonestReadout":46},[310],{"nctId":44,"briefTitle":45,"status":116,"phases":311,"primaryCompletion":46,"completion":270,"start":271,"enrollment":272,"conditions":312,"interventions":313},[88],[274],[47,276,277],{"trials":315,"activeCount":96},[],{"intervention":62,"totalTrials":208,"cells":317},{"EARLY_PHASE1":318,"PHASE1":320,"PHASE2":322,"PHASE3":324,"PHASE4":326,"NA":337},{"trials":319,"activeCount":96},[],{"trials":321,"activeCount":96},[],{"trials":323,"activeCount":96},[],{"trials":325,"activeCount":96},[],{"trials":327,"activeCount":208,"soonestReadout":61},[328],{"nctId":59,"briefTitle":60,"status":116,"phases":329,"primaryCompletion":61,"completion":330,"start":331,"enrollment":332,"conditions":333,"interventions":336},[88],"2027-07-31","2024-01-01",200,[334,335],"Respiratory Distress Syndrome, Newborn","Premature Birth",[62],{"trials":338,"activeCount":96},[],{"intervention":180,"totalTrials":208,"cells":340},{"EARLY_PHASE1":341,"PHASE1":343,"PHASE2":345,"PHASE3":347,"PHASE4":349,"NA":355},{"trials":342,"activeCount":96},[],{"trials":344,"activeCount":96},[],{"trials":346,"activeCount":96},[],{"trials":348,"activeCount":96},[],{"trials":350,"activeCount":208,"soonestReadout":41},[351],{"nctId":39,"briefTitle":40,"status":116,"phases":352,"primaryCompletion":41,"completion":174,"start":175,"enrollment":176,"conditions":353,"interventions":354},[88],[178],[42,180],{"trials":356,"activeCount":96},[],{"intervention":57,"totalTrials":208,"cells":358},{"EARLY_PHASE1":359,"PHASE1":361,"PHASE2":363,"PHASE3":365,"PHASE4":367,"NA":376},{"trials":360,"activeCount":96},[],{"trials":362,"activeCount":96},[],{"trials":364,"activeCount":96},[],{"trials":366,"activeCount":96},[],{"trials":368,"activeCount":208,"soonestReadout":56},[369],{"nctId":54,"briefTitle":55,"status":116,"phases":370,"primaryCompletion":56,"completion":371,"start":331,"enrollment":372,"conditions":373,"interventions":375},[88],"2027-12-01",262,[374],"Respiratory Distress Syndrome",[57],{"trials":377,"activeCount":96},[],{"intervention":82,"totalTrials":208,"cells":379},{"EARLY_PHASE1":380,"PHASE1":382,"PHASE2":384,"PHASE3":386,"PHASE4":388,"NA":408},{"trials":381,"activeCount":96},[],{"trials":383,"activeCount":96},[],{"trials":385,"activeCount":96},[],{"trials":387,"activeCount":96},[],{"trials":389,"activeCount":208,"soonestReadout":81},[390],{"nctId":79,"briefTitle":80,"status":391,"phases":392,"primaryCompletion":81,"completion":393,"start":394,"enrollment":395,"conditions":396,"interventions":407},"ENROLLING_BY_INVITATION",[88],"2027-12","2016-05",3300,[397,398,399,400,401,402,403,404,405,406],"Brain Tumors","Epilepsy","Migraine","Mild Cognitive Impairment","Concussion","Multiple Sclerosis","Neuropathy","Parkinson's","Restless Legs Syndrome","Stroke",[82],{"trials":409,"activeCount":96},[],{"intervention":77,"totalTrials":208,"cells":411},{"EARLY_PHASE1":412,"PHASE1":414,"PHASE2":416,"PHASE3":425,"PHASE4":427,"NA":429},{"trials":413,"activeCount":96},[],{"trials":415,"activeCount":96},[],{"trials":417,"activeCount":208,"soonestReadout":76},[418],{"nctId":74,"briefTitle":75,"status":116,"phases":419,"primaryCompletion":76,"completion":81,"start":420,"enrollment":421,"conditions":422,"interventions":424},[86],"2026-02-26",72,[423],"Overactive Bladder (OAB)",[77],{"trials":426,"activeCount":96},[],{"trials":428,"activeCount":96},[],{"trials":430,"activeCount":96},[],{"intervention":432,"totalTrials":208,"cells":433},"Panzyga IVIG",{"EARLY_PHASE1":434,"PHASE1":436,"PHASE2":438,"PHASE3":454,"PHASE4":456,"NA":458},{"trials":435,"activeCount":96},[],{"trials":437,"activeCount":96},[],{"trials":439,"activeCount":208,"soonestReadout":444},[440],{"nctId":441,"briefTitle":442,"status":116,"phases":443,"primaryCompletion":444,"completion":445,"start":446,"enrollment":447,"conditions":448,"interventions":453},"NCT04153422","IVIG in the Treatment of Autoimmune Small Fiber Neuropathy With TS-HDS, FGFR-3, or Plexin D1 Antibodies",[86],"2027-08-27","2028-02-28","2023-12-15",20,[449,450,451,452],"Small Fiber Neuropathy","Autoimmune Small Fiber Neuropathy","Inflammatory Polyneuropathy","Immune-Mediated Neuropathy",[432],{"trials":455,"activeCount":96},[],{"trials":457,"activeCount":96},[],{"trials":459,"activeCount":96},[],{"intervention":67,"totalTrials":208,"cells":461},{"EARLY_PHASE1":462,"PHASE1":464,"PHASE2":466,"PHASE3":474,"PHASE4":476,"NA":478},{"trials":463,"activeCount":96},[],{"trials":465,"activeCount":96},[],{"trials":467,"activeCount":208,"soonestReadout":66},[468],{"nctId":64,"briefTitle":65,"status":116,"phases":469,"primaryCompletion":66,"completion":66,"start":470,"enrollment":447,"conditions":471,"interventions":473},[86],"2023-12-26",[472],"Adverse Pregnancy Outcome",[67],{"trials":475,"activeCount":96},[],{"trials":477,"activeCount":96},[],{"trials":479,"activeCount":96},[],{"intervention":481,"totalTrials":208,"cells":482},"Adalimumab",{"EARLY_PHASE1":483,"PHASE1":485,"PHASE2":487,"PHASE3":500,"PHASE4":502,"NA":504},{"trials":484,"activeCount":96},[],{"trials":486,"activeCount":96},[],{"trials":488,"activeCount":208,"soonestReadout":493},[489],{"nctId":490,"briefTitle":491,"status":116,"phases":492,"primaryCompletion":493,"completion":494,"start":495,"enrollment":496,"conditions":497,"interventions":499},"NCT06062875","Effects of TNF Blockade on Human BPH\u002FLUTS",[86],"2028-04-01","2028-06-01","2024-01-24",70,[498],"Benign Prostatic Hyperplasia (BPH)",[481],{"trials":501,"activeCount":96},[],{"trials":503,"activeCount":96},[],{"trials":505,"activeCount":96},[],{"intervention":52,"totalTrials":208,"cells":507},{"EARLY_PHASE1":508,"PHASE1":510,"PHASE2":512,"PHASE3":521,"PHASE4":523,"NA":525},{"trials":509,"activeCount":96},[],{"trials":511,"activeCount":96},[],{"trials":513,"activeCount":208,"soonestReadout":51},[514],{"nctId":49,"briefTitle":50,"status":116,"phases":515,"primaryCompletion":51,"completion":393,"start":516,"enrollment":143,"conditions":517,"interventions":519},[86],"2018-06-13",[518],"Knee Osteoarthritis",[52,520],"HA Treatment",{"trials":522,"activeCount":96},[],{"trials":524,"activeCount":96},[],{"trials":526,"activeCount":96},[],{"intervention":520,"totalTrials":208,"cells":528},{"EARLY_PHASE1":529,"PHASE1":531,"PHASE2":533,"PHASE3":539,"PHASE4":541,"NA":543},{"trials":530,"activeCount":96},[],{"trials":532,"activeCount":96},[],{"trials":534,"activeCount":208,"soonestReadout":51},[535],{"nctId":49,"briefTitle":50,"status":116,"phases":536,"primaryCompletion":51,"completion":393,"start":516,"enrollment":143,"conditions":537,"interventions":538},[86],[518],[52,520],{"trials":540,"activeCount":96},[],{"trials":542,"activeCount":96},[],{"trials":544,"activeCount":96},[],{"intervention":546,"totalTrials":208,"cells":547},"Genetic Assessment",{"EARLY_PHASE1":548,"PHASE1":550,"PHASE2":552,"PHASE3":554,"PHASE4":556,"NA":558},{"trials":549,"activeCount":96},[],{"trials":551,"activeCount":96},[],{"trials":553,"activeCount":96},[],{"trials":555,"activeCount":96},[],{"trials":557,"activeCount":96},[],{"trials":559,"activeCount":208,"soonestReadout":564},[560],{"nctId":561,"briefTitle":562,"status":116,"phases":563,"primaryCompletion":564,"completion":565,"start":566,"enrollment":567,"conditions":568,"interventions":569},"NCT05295407","Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy",[],"2026-12-13","2027-12-13","2021-12-13",1000,[15],[546],{"intervention":571,"totalTrials":208,"cells":572},"Carboplatin",{"EARLY_PHASE1":573,"PHASE1":575,"PHASE2":577,"PHASE3":579,"PHASE4":581,"NA":583},{"trials":574,"activeCount":96},[],{"trials":576,"activeCount":96},[],{"trials":578,"activeCount":96},[],{"trials":580,"activeCount":96},[],{"trials":582,"activeCount":96},[],{"trials":584,"activeCount":208,"soonestReadout":494},[585],{"nctId":586,"briefTitle":587,"status":588,"phases":589,"primaryCompletion":494,"completion":590,"start":591,"enrollment":592,"conditions":593,"interventions":596},"NCT05921149","Fasting Mimicking Diet (FMD) in Conjunction With Chemotherapy in Advanced Ovarian Cancer","NOT_YET_RECRUITING",[89],"2031-06-01","2024-05-25",170,[594,595],"Ovarian Cancer","Chemotherapeutic Toxicity",[571,597],"Paclitaxel",{"intervention":597,"totalTrials":208,"cells":599},{"EARLY_PHASE1":600,"PHASE1":602,"PHASE2":604,"PHASE3":606,"PHASE4":608,"NA":610},{"trials":601,"activeCount":96},[],{"trials":603,"activeCount":96},[],{"trials":605,"activeCount":96},[],{"trials":607,"activeCount":96},[],{"trials":609,"activeCount":96},[],{"trials":611,"activeCount":208,"soonestReadout":494},[612],{"nctId":586,"briefTitle":587,"status":588,"phases":613,"primaryCompletion":494,"completion":590,"start":591,"enrollment":592,"conditions":614,"interventions":615},[89],[594,595],[571,597],{"intervention":72,"totalTrials":208,"cells":617},{"EARLY_PHASE1":618,"PHASE1":620,"PHASE2":622,"PHASE3":624,"PHASE4":626,"NA":628},{"trials":619,"activeCount":96},[],{"trials":621,"activeCount":96},[],{"trials":623,"activeCount":96},[],{"trials":625,"activeCount":96},[],{"trials":627,"activeCount":96},[],{"trials":629,"activeCount":208,"soonestReadout":71},[630],{"nctId":69,"briefTitle":70,"status":631,"phases":632,"primaryCompletion":71,"completion":633,"start":634,"enrollment":635,"conditions":636,"interventions":639},"ACTIVE_NOT_RECRUITING",[],"2027-04","2023-04-25",800,[637,638],"Post Operative Pain","Quality of Recovery After Mastectomy",[72],{"intervention":641,"totalTrials":208,"cells":642},"Neostigmine Group",{"EARLY_PHASE1":643,"PHASE1":645,"PHASE2":647,"PHASE3":649,"PHASE4":651,"NA":663},{"trials":644,"activeCount":96},[],{"trials":646,"activeCount":96},[],{"trials":648,"activeCount":96},[],{"trials":650,"activeCount":96},[],{"trials":652,"activeCount":96},[653],{"nctId":654,"briefTitle":655,"status":128,"phases":656,"primaryCompletion":657,"completion":658,"start":659,"enrollment":165,"conditions":660,"interventions":662},"NCT02433808","Neostigmine Reversal And Neuromuscular Recovery",[88],"2016-12","2017-04","2015-04",[661],"Residual Neuromuscular Block",[641],{"trials":664,"activeCount":96},[],{"intervention":666,"totalTrials":208,"cells":667},"bupivacaine, triamcinolone, and heparin",{"EARLY_PHASE1":668,"PHASE1":670,"PHASE2":672,"PHASE3":674,"PHASE4":676,"NA":691},{"trials":669,"activeCount":96},[],{"trials":671,"activeCount":96},[],{"trials":673,"activeCount":96},[],{"trials":675,"activeCount":96},[],{"trials":677,"activeCount":96},[678],{"nctId":679,"briefTitle":680,"status":128,"phases":681,"primaryCompletion":682,"completion":683,"start":684,"enrollment":685,"conditions":686,"interventions":689},"NCT05223244","Bladder Capacity as Objective Measure of Intravesical Treatment of Newly Diagnosed IC",[88],"2019-04-01","2020-03-30","2011-10-01",83,[687,688],"Interstitial Cystitis","Painful Bladder Syndrome",[666,690],"dimethyl sulfoxide",{"trials":692,"activeCount":96},[],{"intervention":690,"totalTrials":208,"cells":694},{"EARLY_PHASE1":695,"PHASE1":697,"PHASE2":699,"PHASE3":701,"PHASE4":703,"NA":709},{"trials":696,"activeCount":96},[],{"trials":698,"activeCount":96},[],{"trials":700,"activeCount":96},[],{"trials":702,"activeCount":96},[],{"trials":704,"activeCount":96},[705],{"nctId":679,"briefTitle":680,"status":128,"phases":706,"primaryCompletion":682,"completion":683,"start":684,"enrollment":685,"conditions":707,"interventions":708},[88],[687,688],[666,690],{"trials":710,"activeCount":96},[],{"intervention":712,"totalTrials":208,"cells":713},"Naproxen Sodium",{"EARLY_PHASE1":714,"PHASE1":716,"PHASE2":718,"PHASE3":720,"PHASE4":722,"NA":739},{"trials":715,"activeCount":96},[],{"trials":717,"activeCount":96},[],{"trials":719,"activeCount":96},[],{"trials":721,"activeCount":96},[],{"trials":723,"activeCount":96},[724],{"nctId":725,"briefTitle":726,"status":128,"phases":727,"primaryCompletion":728,"completion":728,"start":729,"enrollment":730,"conditions":731,"interventions":738},"NCT04145518","Mechanistic Characterization of Uterine Pain",[88],"2025-07-23","2019-10-25",183,[732,733,734,735,736,737],"Dysmenorrhea (Disorder)","Dysmenorrhea Primary","Dysmenorrhea Secondary","Endometrial Diseases","Leiomyoma","Fibroid Uterus",[712],{"trials":740,"activeCount":96},[],{"intervention":742,"totalTrials":208,"cells":743},"Naproxen",{"EARLY_PHASE1":744,"PHASE1":746,"PHASE2":748,"PHASE3":750,"PHASE4":752,"NA":764},{"trials":745,"activeCount":96},[],{"trials":747,"activeCount":96},[],{"trials":749,"activeCount":96},[],{"trials":751,"activeCount":96},[],{"trials":753,"activeCount":96},[754],{"nctId":755,"briefTitle":756,"status":128,"phases":757,"primaryCompletion":758,"completion":759,"start":760,"enrollment":761,"conditions":762,"interventions":763},"NCT03697720","Examining the Role of Improved NSAID Management in Treating Dysmenorrhea and Bladder Pain",[88],"2020-11-23","2023-09-27","2018-05-09",26,[21,31],[742],{"trials":765,"activeCount":96},[],{"intervention":767,"totalTrials":208,"cells":768},"low-dose naltrexone",{"EARLY_PHASE1":769,"PHASE1":771,"PHASE2":773,"PHASE3":775,"PHASE4":777,"NA":792},{"trials":770,"activeCount":96},[],{"trials":772,"activeCount":96},[],{"trials":774,"activeCount":96},[],{"trials":776,"activeCount":96},[],{"trials":778,"activeCount":96},[779],{"nctId":780,"briefTitle":781,"status":108,"phases":782,"primaryCompletion":783,"completion":784,"start":785,"enrollment":19,"conditions":786,"interventions":791},"NCT04313972","IC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone",[88],"2023-01-23","2023-02-23","2021-09-07",[687,688,787,788,789,790],"Bladder Pain Syndrome","Low Dose Naltrexone","Low-dose Naltrexone","Naltrexone",[767],{"trials":793,"activeCount":96},[],{"intervention":158,"totalTrials":208,"cells":795},{"EARLY_PHASE1":796,"PHASE1":798,"PHASE2":800,"PHASE3":802,"PHASE4":804,"NA":810},{"trials":797,"activeCount":96},[],{"trials":799,"activeCount":96},[],{"trials":801,"activeCount":96},[],{"trials":803,"activeCount":96},[],{"trials":805,"activeCount":96},[806],{"nctId":147,"briefTitle":148,"status":128,"phases":807,"primaryCompletion":150,"completion":151,"start":152,"enrollment":153,"conditions":808,"interventions":809},[88],[155,156],[42,158],{"trials":811,"activeCount":96},[],{"intervention":813,"totalTrials":208,"cells":814},"Trimethoprim",{"EARLY_PHASE1":815,"PHASE1":817,"PHASE2":819,"PHASE3":821,"PHASE4":823,"NA":836},{"trials":816,"activeCount":96},[],{"trials":818,"activeCount":96},[],{"trials":820,"activeCount":96},[],{"trials":822,"activeCount":96},[],{"trials":824,"activeCount":96},[825],{"nctId":826,"briefTitle":827,"status":128,"phases":828,"primaryCompletion":829,"completion":829,"start":830,"enrollment":831,"conditions":832,"interventions":834},"NCT03077711","Methenamine Hippurate Versus Trimethoprim in the Prevention of Recurrent UTIs",[88],"2019-06-21","2016-06",92,[833],"Urinary Tract Infections, Recurrent",[813,835],"Methenamine hippurate",{"trials":837,"activeCount":96},[],{"intervention":835,"totalTrials":208,"cells":839},{"EARLY_PHASE1":840,"PHASE1":842,"PHASE2":844,"PHASE3":846,"PHASE4":848,"NA":854},{"trials":841,"activeCount":96},[],{"trials":843,"activeCount":96},[],{"trials":845,"activeCount":96},[],{"trials":847,"activeCount":96},[],{"trials":849,"activeCount":96},[850],{"nctId":826,"briefTitle":827,"status":128,"phases":851,"primaryCompletion":829,"completion":829,"start":830,"enrollment":831,"conditions":852,"interventions":853},[88],[833],[813,835],{"trials":855,"activeCount":96},[],{"intervention":857,"totalTrials":208,"cells":858},"Control-saline",{"EARLY_PHASE1":859,"PHASE1":861,"PHASE2":863,"PHASE3":865,"PHASE4":867,"NA":881},{"trials":860,"activeCount":96},[],{"trials":862,"activeCount":96},[],{"trials":864,"activeCount":96},[],{"trials":866,"activeCount":96},[],{"trials":868,"activeCount":96},[869],{"nctId":870,"briefTitle":871,"status":128,"phases":872,"primaryCompletion":873,"completion":873,"start":874,"enrollment":332,"conditions":875,"interventions":877},"NCT01545700","Effect of Low-Dose Dexamethasone on the Incidence of Hyperglycemia Following Surgery",[88],"2012-11","2009-09",[876],"Postoperative Complications",[857,878,879,880,878,879],"Dexamethasone 4 mg","Dexamethasone 8 mg","Control saline",{"trials":882,"activeCount":96},[],{"intervention":878,"totalTrials":208,"cells":884},{"EARLY_PHASE1":885,"PHASE1":887,"PHASE2":889,"PHASE3":891,"PHASE4":893,"NA":899},{"trials":886,"activeCount":96},[],{"trials":888,"activeCount":96},[],{"trials":890,"activeCount":96},[],{"trials":892,"activeCount":96},[],{"trials":894,"activeCount":96},[895],{"nctId":870,"briefTitle":871,"status":128,"phases":896,"primaryCompletion":873,"completion":873,"start":874,"enrollment":332,"conditions":897,"interventions":898},[88],[876],[857,878,879,880,878,879],{"trials":900,"activeCount":96},[],{"intervention":879,"totalTrials":208,"cells":902},{"EARLY_PHASE1":903,"PHASE1":905,"PHASE2":907,"PHASE3":909,"PHASE4":911,"NA":917},{"trials":904,"activeCount":96},[],{"trials":906,"activeCount":96},[],{"trials":908,"activeCount":96},[],{"trials":910,"activeCount":96},[],{"trials":912,"activeCount":96},[913],{"nctId":870,"briefTitle":871,"status":128,"phases":914,"primaryCompletion":873,"completion":873,"start":874,"enrollment":332,"conditions":915,"interventions":916},[88],[876],[857,878,879,880,878,879],{"trials":918,"activeCount":96},[],{"intervention":880,"totalTrials":208,"cells":920},{"EARLY_PHASE1":921,"PHASE1":923,"PHASE2":925,"PHASE3":927,"PHASE4":929,"NA":935},{"trials":922,"activeCount":96},[],{"trials":924,"activeCount":96},[],{"trials":926,"activeCount":96},[],{"trials":928,"activeCount":96},[],{"trials":930,"activeCount":96},[931],{"nctId":870,"briefTitle":871,"status":128,"phases":932,"primaryCompletion":873,"completion":873,"start":874,"enrollment":332,"conditions":933,"interventions":934},[88],[876],[857,878,879,880,878,879],{"trials":936,"activeCount":96},[],{"intervention":938,"totalTrials":208,"cells":939},"Dexamethasone",{"EARLY_PHASE1":940,"PHASE1":942,"PHASE2":944,"PHASE3":946,"PHASE4":948,"NA":960},{"trials":941,"activeCount":96},[],{"trials":943,"activeCount":96},[],{"trials":945,"activeCount":96},[],{"trials":947,"activeCount":96},[],{"trials":949,"activeCount":96},[950],{"nctId":951,"briefTitle":952,"status":108,"phases":953,"primaryCompletion":954,"completion":954,"start":955,"enrollment":332,"conditions":956,"interventions":959},"NCT02109081","Dexamethasone and Postoperative Delirium",[88],"2021-02","2014-04",[957,958],"Delirium","Postoperative Cognitive Dysfunction",[938],{"trials":961,"activeCount":96},[],{"intervention":963,"totalTrials":208,"cells":964},"Ketamine",{"EARLY_PHASE1":965,"PHASE1":967,"PHASE2":969,"PHASE3":971,"PHASE4":973,"NA":982},{"trials":966,"activeCount":96},[],{"trials":968,"activeCount":96},[],{"trials":970,"activeCount":96},[],{"trials":972,"activeCount":96},[],{"trials":974,"activeCount":96},[975],{"nctId":976,"briefTitle":977,"status":128,"phases":978,"primaryCompletion":954,"completion":954,"start":142,"enrollment":176,"conditions":979,"interventions":980},"NCT02827526","Methadone and Ketamine for Spinal Surgery",[88],[31],[963,981],"Control",{"trials":983,"activeCount":96},[],{"intervention":981,"totalTrials":208,"cells":985},{"EARLY_PHASE1":986,"PHASE1":988,"PHASE2":990,"PHASE3":992,"PHASE4":994,"NA":1000},{"trials":987,"activeCount":96},[],{"trials":989,"activeCount":96},[],{"trials":991,"activeCount":96},[],{"trials":993,"activeCount":96},[],{"trials":995,"activeCount":96},[996],{"nctId":976,"briefTitle":977,"status":128,"phases":997,"primaryCompletion":954,"completion":954,"start":142,"enrollment":176,"conditions":998,"interventions":999},[88],[31],[963,981],{"trials":1001,"activeCount":96},[],{"intervention":1003,"totalTrials":208,"cells":1004},"cyclic microgestin 1\u002F20",{"EARLY_PHASE1":1005,"PHASE1":1007,"PHASE2":1009,"PHASE3":1011,"PHASE4":1013,"NA":1030},{"trials":1006,"activeCount":96},[],{"trials":1008,"activeCount":96},[],{"trials":1010,"activeCount":96},[],{"trials":1012,"activeCount":96},[],{"trials":1014,"activeCount":96},[1015],{"nctId":1016,"briefTitle":1017,"status":128,"phases":1018,"primaryCompletion":1019,"completion":1020,"start":1021,"enrollment":1022,"conditions":1023,"interventions":1028},"NCT02214550","Chronic Pain Risk Associated With Menstrual Period Pain",[88],"2020-11","2021-01","2014-07",353,[1024,21,1025,23,1026,1027,156],"Cystitis, Interstitial","Migraine Disorders","Endometriosis","Visceral Pain",[1003,1029],"continuous microgestin 1\u002F20",{"trials":1031,"activeCount":96},[],{"intervention":1029,"totalTrials":208,"cells":1033},{"EARLY_PHASE1":1034,"PHASE1":1036,"PHASE2":1038,"PHASE3":1040,"PHASE4":1042,"NA":1048},{"trials":1035,"activeCount":96},[],{"trials":1037,"activeCount":96},[],{"trials":1039,"activeCount":96},[],{"trials":1041,"activeCount":96},[],{"trials":1043,"activeCount":96},[1044],{"nctId":1016,"briefTitle":1017,"status":128,"phases":1045,"primaryCompletion":1019,"completion":1020,"start":1021,"enrollment":1022,"conditions":1046,"interventions":1047},[88],[1024,21,1025,23,1026,1027,156],[1003,1029],{"trials":1049,"activeCount":96},[],{"intervention":1051,"totalTrials":208,"cells":1052},"Acetaminophen",{"EARLY_PHASE1":1053,"PHASE1":1055,"PHASE2":1057,"PHASE3":1059,"PHASE4":1061,"NA":1074},{"trials":1054,"activeCount":96},[],{"trials":1056,"activeCount":96},[],{"trials":1058,"activeCount":96},[],{"trials":1060,"activeCount":96},[],{"trials":1062,"activeCount":96},[1063],{"nctId":1064,"briefTitle":1065,"status":128,"phases":1066,"primaryCompletion":1067,"completion":1068,"start":1069,"enrollment":120,"conditions":1070,"interventions":1073},"NCT01739699","The Efficacy of Intravenous Acetaminophen During Perioperative Neurosurgery Period",[88],"2016-08-01","2017-01-20","2012-01",[1071,1072],"Craniotomy","Brain Surgery",[1051],{"trials":1075,"activeCount":96},[],{"intervention":1077,"totalTrials":208,"cells":1078},"Tizanidine",{"EARLY_PHASE1":1079,"PHASE1":1081,"PHASE2":1083,"PHASE3":1085,"PHASE4":1099,"NA":1101},{"trials":1080,"activeCount":96},[],{"trials":1082,"activeCount":96},[],{"trials":1084,"activeCount":96},[],{"trials":1086,"activeCount":96},[1087],{"nctId":1088,"briefTitle":1089,"status":128,"phases":1090,"primaryCompletion":1091,"completion":1092,"start":1093,"enrollment":447,"conditions":1094,"interventions":1098},"NCT06258785","Effect of Tizanidine on Postoperative Urinary Retention After Sacrospinous Suspension",[87],"2025-09-15","2025-10-24","2024-09-17",[1095,1096,1097],"Postoperative Urinary Retention","Sacrospinous Vaginal Vault Suspension","Reconstructive Pelvic Surgery",[1077],{"trials":1100,"activeCount":96},[],{"trials":1102,"activeCount":96},[],{"intervention":1104,"totalTrials":208,"cells":1105},"Tamsulosin",{"EARLY_PHASE1":1106,"PHASE1":1108,"PHASE2":1110,"PHASE3":1112,"PHASE4":1125,"NA":1127},{"trials":1107,"activeCount":96},[],{"trials":1109,"activeCount":96},[],{"trials":1111,"activeCount":96},[],{"trials":1113,"activeCount":96},[1114],{"nctId":1115,"briefTitle":1116,"status":128,"phases":1117,"primaryCompletion":1118,"completion":1119,"start":1120,"enrollment":1121,"conditions":1122,"interventions":1124},"NCT05753670","Effect of Preoperative Tamsulosin on Postoperative Urinary Retention",[87],"2024-05-02","2024-06-02","2023-07-01",179,[1123],"Postoperative Retention of Urine",[1104],{"trials":1126,"activeCount":96},[],{"trials":1128,"activeCount":96},[],{"intervention":1130,"totalTrials":208,"cells":1131},"Dutasteride",{"EARLY_PHASE1":1132,"PHASE1":1134,"PHASE2":1136,"PHASE3":1146,"PHASE4":1148,"NA":1150},{"trials":1133,"activeCount":96},[],{"trials":1135,"activeCount":96},[],{"trials":1137,"activeCount":96},[1138],{"nctId":1139,"briefTitle":1140,"status":128,"phases":1141,"primaryCompletion":1142,"completion":1142,"start":1143,"enrollment":447,"conditions":1144,"interventions":1145},"NCT00668642","Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer",[86],"2013-05","2007-03",[15],[1130],{"trials":1147,"activeCount":96},[],{"trials":1149,"activeCount":96},[],{"trials":1151,"activeCount":96},[],{"intervention":1153,"totalTrials":208,"cells":1154},"5-aminolevulinic acid",{"EARLY_PHASE1":1155,"PHASE1":1157,"PHASE2":1159,"PHASE3":1170,"PHASE4":1172,"NA":1174},{"trials":1156,"activeCount":96},[],{"trials":1158,"activeCount":96},[],{"trials":1160,"activeCount":96},[1161],{"nctId":1162,"briefTitle":1163,"status":1164,"phases":1165,"primaryCompletion":1166,"completion":1166,"start":874,"enrollment":96,"conditions":1167,"interventions":1169},"NCT00977795","A Study of the Specificity and Sensitivity of 5-ALA Fluorescence in Malignant Brain Tumors","WITHDRAWN",[85,86],"2010-01",[1168],"Brain Neoplasms",[1153],{"trials":1171,"activeCount":96},[],{"trials":1173,"activeCount":96},[],{"trials":1175,"activeCount":96},[],{"intervention":1177,"totalTrials":208,"cells":1178},"5 Fluorouracil",{"EARLY_PHASE1":1179,"PHASE1":1181,"PHASE2":1183,"PHASE3":1198,"PHASE4":1200,"NA":1202},{"trials":1180,"activeCount":96},[],{"trials":1182,"activeCount":96},[],{"trials":1184,"activeCount":96},[1185],{"nctId":1186,"briefTitle":1187,"status":128,"phases":1188,"primaryCompletion":1189,"completion":1189,"start":1190,"enrollment":1191,"conditions":1192,"interventions":1194},"NCT01660711","A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic Adenocarcinoma",[86],"2018-08-22","2012-07",22,[1193],"Pancreatic Adenocarcinoma",[1177,1195,1196,1197],"Leucovorin","Irinotecan","Oxaliplatin",{"trials":1199,"activeCount":96},[],{"trials":1201,"activeCount":96},[],{"trials":1203,"activeCount":96},[],{"intervention":1195,"totalTrials":208,"cells":1205},{"EARLY_PHASE1":1206,"PHASE1":1208,"PHASE2":1210,"PHASE3":1216,"PHASE4":1218,"NA":1220},{"trials":1207,"activeCount":96},[],{"trials":1209,"activeCount":96},[],{"trials":1211,"activeCount":96},[1212],{"nctId":1186,"briefTitle":1187,"status":128,"phases":1213,"primaryCompletion":1189,"completion":1189,"start":1190,"enrollment":1191,"conditions":1214,"interventions":1215},[86],[1193],[1177,1195,1196,1197],{"trials":1217,"activeCount":96},[],{"trials":1219,"activeCount":96},[],{"trials":1221,"activeCount":96},[],{"intervention":1196,"totalTrials":208,"cells":1223},{"EARLY_PHASE1":1224,"PHASE1":1226,"PHASE2":1228,"PHASE3":1234,"PHASE4":1236,"NA":1238},{"trials":1225,"activeCount":96},[],{"trials":1227,"activeCount":96},[],{"trials":1229,"activeCount":96},[1230],{"nctId":1186,"briefTitle":1187,"status":128,"phases":1231,"primaryCompletion":1189,"completion":1189,"start":1190,"enrollment":1191,"conditions":1232,"interventions":1233},[86],[1193],[1177,1195,1196,1197],{"trials":1235,"activeCount":96},[],{"trials":1237,"activeCount":96},[],{"trials":1239,"activeCount":96},[],{"intervention":1197,"totalTrials":208,"cells":1241},{"EARLY_PHASE1":1242,"PHASE1":1244,"PHASE2":1246,"PHASE3":1252,"PHASE4":1254,"NA":1256},{"trials":1243,"activeCount":96},[],{"trials":1245,"activeCount":96},[],{"trials":1247,"activeCount":96},[1248],{"nctId":1186,"briefTitle":1187,"status":128,"phases":1249,"primaryCompletion":1189,"completion":1189,"start":1190,"enrollment":1191,"conditions":1250,"interventions":1251},[86],[1193],[1177,1195,1196,1197],{"trials":1253,"activeCount":96},[],{"trials":1255,"activeCount":96},[],{"trials":1257,"activeCount":96},[],{"intervention":1259,"totalTrials":208,"cells":1260},"Relugolix (40 mg) \u002Festradiol (1 mg)\u002Fnorethisterone acetate (0.5 mg) oral",{"EARLY_PHASE1":1261,"PHASE1":1263,"PHASE2":1265,"PHASE3":1275,"PHASE4":1277,"NA":1279},{"trials":1262,"activeCount":96},[],{"trials":1264,"activeCount":96},[],{"trials":1266,"activeCount":96},[1267],{"nctId":1268,"briefTitle":1269,"status":1164,"phases":1270,"primaryCompletion":1271,"completion":1271,"start":1272,"enrollment":96,"conditions":1273,"interventions":1274},"NCT06279195","Phenotyping of Idiopathic Pelvic Pain With Real-time Uterine Imaging and Relugolix-Combination Therapy Treatment",[86],"2025-11-02","2024-06-01",[23],[1259],{"trials":1276,"activeCount":96},[],{"trials":1278,"activeCount":96},[],{"trials":1280,"activeCount":96},[],{"intervention":1282,"totalTrials":208,"cells":1283},"Erlotinib",{"EARLY_PHASE1":1284,"PHASE1":1286,"PHASE2":1288,"PHASE3":1299,"PHASE4":1301,"NA":1303},{"trials":1285,"activeCount":96},[],{"trials":1287,"activeCount":96},[],{"trials":1289,"activeCount":96},[1290],{"nctId":1291,"briefTitle":1292,"status":128,"phases":1293,"primaryCompletion":1294,"completion":1294,"start":1295,"enrollment":1296,"conditions":1297,"interventions":1298},"NCT00148772","Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy",[86],"2008-08","2005-08",29,[15],[1282],{"trials":1300,"activeCount":96},[],{"trials":1302,"activeCount":96},[],{"trials":1304,"activeCount":96},[],{"intervention":1306,"totalTrials":208,"cells":1307},"FMT",{"EARLY_PHASE1":1308,"PHASE1":1310,"PHASE2":1312,"PHASE3":1325,"PHASE4":1327,"NA":1329},{"trials":1309,"activeCount":96},[],{"trials":1311,"activeCount":96},[],{"trials":1313,"activeCount":96},[1314],{"nctId":1315,"briefTitle":1316,"status":108,"phases":1317,"primaryCompletion":1318,"completion":1318,"start":1319,"enrollment":1320,"conditions":1321,"interventions":1323},"NCT02255305","FMT Versus Antimicrobials for Initial Treatment of Recurrent CDI",[86],"2020-01","2015-01",6,[1322],"Clostridium Difficile Infection",[1306,1324],"Antimicrobials",{"trials":1326,"activeCount":96},[],{"trials":1328,"activeCount":96},[],{"trials":1330,"activeCount":96},[],{"intervention":1324,"totalTrials":208,"cells":1332},{"EARLY_PHASE1":1333,"PHASE1":1335,"PHASE2":1337,"PHASE3":1343,"PHASE4":1345,"NA":1347},{"trials":1334,"activeCount":96},[],{"trials":1336,"activeCount":96},[],{"trials":1338,"activeCount":96},[1339],{"nctId":1315,"briefTitle":1316,"status":108,"phases":1340,"primaryCompletion":1318,"completion":1318,"start":1319,"enrollment":1320,"conditions":1341,"interventions":1342},[86],[1322],[1306,1324],{"trials":1344,"activeCount":96},[],{"trials":1346,"activeCount":96},[],{"trials":1348,"activeCount":96},[],{"intervention":1350,"totalTrials":208,"cells":1351},"Rectal dialysis",{"EARLY_PHASE1":1352,"PHASE1":1354,"PHASE2":1356,"PHASE3":1368,"PHASE4":1370,"NA":1372},{"trials":1353,"activeCount":96},[],{"trials":1355,"activeCount":96},[],{"trials":1357,"activeCount":96},[1358],{"nctId":1359,"briefTitle":1360,"status":108,"phases":1361,"primaryCompletion":1362,"completion":1363,"start":1364,"enrollment":181,"conditions":1365,"interventions":1367},"NCT04032652","Use of Rectal Dialysis Technique to Measure Rectal 5-ASA Levels in Healthy Volunteers Receiving Asacol",[86],"2014-11","2014-12-05","2012-12",[1366],"Ulcerative Colitis",[1350],{"trials":1369,"activeCount":96},[],{"trials":1371,"activeCount":96},[],{"trials":1373,"activeCount":96},[],{"intervention":1375,"totalTrials":181,"cells":1376},"Sugammadex",{"EARLY_PHASE1":1377,"PHASE1":1379,"PHASE2":1381,"PHASE3":1383,"PHASE4":1395,"NA":1397},{"trials":1378,"activeCount":96},[],{"trials":1380,"activeCount":96},[],{"trials":1382,"activeCount":96},[],{"trials":1384,"activeCount":96},[1385],{"nctId":1386,"briefTitle":1387,"status":128,"phases":1388,"primaryCompletion":1389,"completion":1389,"start":1390,"enrollment":1391,"conditions":1392,"interventions":1394},"NCT05801679","Evaluating Outcomes in Cardiac Surgery Patients Who Receive Sugammadex vs. Placebo",[87],"2025-07-11","2023-07-03",74,[1393],"Surgery",[1375],{"trials":1396,"activeCount":96},[],{"trials":1398,"activeCount":96},[1399],{"nctId":1400,"briefTitle":1401,"status":128,"phases":1402,"primaryCompletion":1403,"completion":1403,"start":1404,"enrollment":332,"conditions":1405,"interventions":1407},"NCT01837498","Reversal of Neuromuscular Blockade in Thoracic Surgical Patients",[],"2017-03","2014-02",[1406],"Residual Neuromuscular Blockade",[1408,1375],"Neostigmine",{"intervention":1410,"totalTrials":208,"cells":1411},"Lanthanum Carbonate",{"EARLY_PHASE1":1412,"PHASE1":1414,"PHASE2":1416,"PHASE3":1418,"PHASE4":1420,"NA":1422},{"trials":1413,"activeCount":96},[],{"trials":1415,"activeCount":96},[],{"trials":1417,"activeCount":96},[],{"trials":1419,"activeCount":96},[],{"trials":1421,"activeCount":96},[],{"trials":1423,"activeCount":96},[1424],{"nctId":1425,"briefTitle":1426,"status":128,"phases":1427,"primaryCompletion":1428,"completion":1364,"start":1429,"enrollment":1430,"conditions":1431,"interventions":1433},"NCT01002872","The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 ( FGF23) in Chronic Kidney Disease",[89],"2012-05","2009-10",19,[1432],"Metabolic Bone Disease",[1410],{"intervention":1435,"totalTrials":208,"cells":1436},"hydrocortisone",{"EARLY_PHASE1":1437,"PHASE1":1439,"PHASE2":1441,"PHASE3":1443,"PHASE4":1445,"NA":1447},{"trials":1438,"activeCount":96},[],{"trials":1440,"activeCount":96},[],{"trials":1442,"activeCount":96},[],{"trials":1444,"activeCount":96},[],{"trials":1446,"activeCount":96},[],{"trials":1448,"activeCount":96},[1449],{"nctId":1450,"briefTitle":1451,"status":108,"phases":1452,"primaryCompletion":873,"completion":873,"start":874,"enrollment":181,"conditions":1453,"interventions":1455},"NCT01156480","Anti-inflammatory Treatment at the Onset of Necrotizing Enterocolitis (NEC) in Preterm Infants",[89],[1454],"Necrotizing Enterocolitis",[1435],{"intervention":1408,"totalTrials":208,"cells":1457},{"EARLY_PHASE1":1458,"PHASE1":1460,"PHASE2":1462,"PHASE3":1464,"PHASE4":1466,"NA":1468},{"trials":1459,"activeCount":96},[],{"trials":1461,"activeCount":96},[],{"trials":1463,"activeCount":96},[],{"trials":1465,"activeCount":96},[],{"trials":1467,"activeCount":96},[],{"trials":1469,"activeCount":96},[1470],{"nctId":1400,"briefTitle":1401,"status":128,"phases":1471,"primaryCompletion":1403,"completion":1403,"start":1404,"enrollment":332,"conditions":1472,"interventions":1473},[],[1406],[1408,1375],{"intervention":1475,"totalTrials":208,"cells":1476},"Decolonization",{"EARLY_PHASE1":1477,"PHASE1":1479,"PHASE2":1481,"PHASE3":1483,"PHASE4":1485,"NA":1487},{"trials":1478,"activeCount":96},[],{"trials":1480,"activeCount":96},[],{"trials":1482,"activeCount":96},[],{"trials":1484,"activeCount":96},[],{"trials":1486,"activeCount":96},[],{"trials":1488,"activeCount":96},[1489],{"nctId":1490,"briefTitle":1491,"status":128,"phases":1492,"primaryCompletion":1493,"completion":1362,"start":1494,"enrollment":1495,"conditions":1496,"interventions":1498},"NCT01302210","Detection, Education, Research and Decolonization Without Isolation in Long-term Care Facilities",[],"2013-12","2010-10",22302,[1497],"Methicillin Resistant Staphylococcus Aureus",[1475],{"intervention":1500,"totalTrials":208,"cells":1501},"cyclobenzaprine",{"EARLY_PHASE1":1502,"PHASE1":1504,"PHASE2":1506,"PHASE3":1508,"PHASE4":1510,"NA":1512},{"trials":1503,"activeCount":96},[],{"trials":1505,"activeCount":96},[],{"trials":1507,"activeCount":96},[],{"trials":1509,"activeCount":96},[],{"trials":1511,"activeCount":96},[],{"trials":1513,"activeCount":96},[1514],{"nctId":1515,"briefTitle":1516,"status":128,"phases":1517,"primaryCompletion":1021,"completion":1518,"start":1519,"enrollment":1520,"conditions":1521,"interventions":1522},"NCT01081990","Use of Cyclobenzaprine After Vaginal Surgery",[89],"2014-08-01","2010-04",63,[18],[1500],{"intervention":1524,"totalTrials":208,"cells":1525},"Genetic Risk Score: Number Format",{"EARLY_PHASE1":1526,"PHASE1":1528,"PHASE2":1530,"PHASE3":1532,"PHASE4":1534,"NA":1536},{"trials":1527,"activeCount":96},[],{"trials":1529,"activeCount":96},[],{"trials":1531,"activeCount":96},[],{"trials":1533,"activeCount":96},[],{"trials":1535,"activeCount":96},[],{"trials":1537,"activeCount":96},[1538],{"nctId":1539,"briefTitle":1540,"status":128,"phases":1541,"primaryCompletion":1542,"completion":1542,"start":1543,"enrollment":1544,"conditions":1545,"interventions":1548},"NCT02381015","Clinical Validity and Utility of Genomic-targeted Chemoprevention of PCa: Aim 4a",[89],"2012-06","2011-06",700,[15,1546,1547],"Prostate Cancer, Familial","Hereditary Prostate Cancer",[1524,1549],"Genetic Risk Score: Number + Pictograph",{"intervention":1549,"totalTrials":208,"cells":1551},{"EARLY_PHASE1":1552,"PHASE1":1554,"PHASE2":1556,"PHASE3":1558,"PHASE4":1560,"NA":1562},{"trials":1553,"activeCount":96},[],{"trials":1555,"activeCount":96},[],{"trials":1557,"activeCount":96},[],{"trials":1559,"activeCount":96},[],{"trials":1561,"activeCount":96},[],{"trials":1563,"activeCount":96},[1564],{"nctId":1539,"briefTitle":1540,"status":128,"phases":1565,"primaryCompletion":1542,"completion":1542,"start":1543,"enrollment":1544,"conditions":1566,"interventions":1567},[89],[15,1546,1547],[1524,1549]]